NanoSyrinx is a discovery stage synthetic biology company, spun-out of the University of Warwick’s Medical School, creating a next-generation platform technology for the targeted intracellular delivery of biological molecules. Most drugs do not traverse the body well, limiting their effectiveness. This is an even greater problem for biologic drugs, such as antibodies and peptides; and consequently new delivery modalities are sorely needed.
We are on a mission to fundamentally revolutionise how medicines are administered – on a nanoscopic scale.
Building on over a decade of fundamental research, our scientists are harnessing the unique properties of Nature’s own elegant solution to the intracellular bioavailability problem.